Loading...
Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients | NEJM Clinician
NEJM Research Summary
Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients
New England Journal of Medicine
May 5
1 min read
New England Journal of Medicine
May 5
1 min read
New England Journal of Medicine
May 5
1 min read
Related Content
Original Article
Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients
Topics
Infectious Disease
Coronavirus
Clinical Medicine
Outpatient-Based Clinical Medicine